Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Any kind of exercise helps control diabetes but combo of aerobic and resistance training the best

According to Canadian researchers any kind of exercise is better than none when it comes to controling type-2 diabetes.

18 Sep 2007

Combined aerobic and resistance training best for people with diabetes

In a new randomized controlled trial, both aerobic and resistance exercise improved glycemic/blood sugar control in people with type 2 diabetes.

18 Sep 2007

Effects of modified alternate-day fasting

Researchers report in the October issue of the Journal of Lipid Research that fasting or eating half as much as usual every other day may shrink your fat cells and boost mechanisms that break down fats.

18 Sep 2007

Immune system police recognize good and bad guys in the body

Immune system police are as good at recognizing bad guys, such as bacteria and viruses, as they are our own tissue, researchers say.

17 Sep 2007

New understanding of immune infertility

Most of us have never heard of immune infertility, yet it prevents many prospective parents from conceiving. Immune infertility is one of 80 autoimmune disorders, a group that includes better-known diseases like Multiple Sclerosis and Type 1 Diabetes.

13 Sep 2007

Researchers question safety of Avandia and it's longterm use

Researchers in the U.S. say the long-term use of a medication used in patients with type 2 Diabetes and people with glucose intolerance, increases the risk for heart failure and heart attacks.

12 Sep 2007

Long-term use of rosiglitazone (Avandia) increases heart attack risk by more than 40 percent

An analysis of four studies involving more than 14,000 patients found that long-term use of the diabetes drug rosiglitazone (Avandia) increased the risk of heart attack by 42 percent and doubled the risk of heart failure, according to a new report from researchers at Wake Forest University School of Medicine and colleagues.

12 Sep 2007

Glycemic control medication appears to have favorable effect regarding risk of cardiovascular events

A meta-analysis of previous research suggests that use of pioglitazone, a glycemic control medication for patients with type 2 diabetes, significantly reduces the risk of heart attack, stroke and death, but increases the risk for serious heart failure, according to an article in the September 12 issue of JAMA: The Journal of the American Medical Association.

12 Sep 2007

GlaxoSmithKline responds to Journal of the American Medical Association articles

GlaxoSmithKline believes that conclusions drawn from the most recent meta-analyses published by Drs. Nissen et. al. and Furberg et. al. in the Journal of the American Medical Association do not confirm a difference in the safety profile of Avandia (rosiglitazone) and Actos (pioglitazone).

12 Sep 2007

Diabetes drug Pioglitazone reduces risk of death, heart attack and stroke, but increases risk of heart failure

A drug widely used to treat type 2 diabetes has been found to reduce the risk of death, heart attack (myocardial infarction) or stroke when used alone or in combination with other therapies for diabetes, according to a Cleveland Clinic study.

12 Sep 2007

Mutations in the insulin gene can cause permanent neonatal diabetes

Mutations in the insulin gene can cause permanent neonatal diabetes, an unusual form of diabetes that affects very young children and results in lifelong dependence on insulin injections, report researchers from the University of Chicago and Peninsula University (Exeter, UK) in Sept. 18, 2007, issue of the Proceedings of the National Academy of Sciences, published early online.

11 Sep 2007

Congestive heart failure is rare among leukemia patients who take imatinib

Congestive heart failure rarely occurs among leukemia patients who take imatinib, researchers at The University of Texas M. D. Anderson Cancer Center found after an exhaustive review of the detailed medical histories of 1,276 patients who enrolled in clinical trials for the drug.

10 Sep 2007

Metformin could potentially improve pregnancy outcomes in women with insulin resistance

Women who are obese, have type 2 diabetes or a family history of type 2 diabetes could one day have more successful pregnancies because of a study at Washington University School of Medicine in St. Louis.

10 Sep 2007

Fatty hearts in pre-diabetics

A simple imaging technique developed by UT Southwestern Medical Center researchers has revealed fat buildup in the hearts of pre-diabetic people long before symptoms of heart disease or diabetes appear.

5 Sep 2007

Immunosuppressive drugs are a double-edged sword to type 1 diabetics

Type 1 diabetes is caused when immune cells attack and destroy the insulin producing beta-cells of the pancreas.

5 Sep 2007

Perindopril - indapamide drug combo cuts death rate in type 2 diabetes

The largest-ever study of treatments for type 2 diabetes has shown that a combination of two blood pressure lowering drugs reduced the risk of death, as well as the risks of heart and kidney disease.

5 Sep 2007

Lower blood pressure to manage type 2 diabetes

A small reduction in blood pressure produced a significant benefit in the largest study ever done on the treatment of patients with type 2 diabetes, presented on Sunday in Vienna at the European Society of Cardiology Congress, and published online in the Lancet the same day.

5 Sep 2007

Blood pressure pill offers diabetics a longer life

A team of Australian researchers say a once-a-day pill to lower blood pressure should be given routinely to people with diabetes to prevent heart disease, strokes and other medical complications.

5 Sep 2007

Role of self monitoring in patients with type 2 diabetes

A new study published on bmj.com calls for better advice about home blood glucose monitoring for patients with non-insulin dependent (type 2) diabetes.Type 2 diabetes usually develops in people over 40, especially when the person is overweight.

3 Sep 2007

Insights into the physiological basis of obesity

The past decade has witnessed an explosion of information regarding the role of the central nervous system (CNS) in the development of obesity and the influence of peripheral, hormonal signals that regulate CNS function to regulate food intake and metabolism.

3 Sep 2007